{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:32:16Z","timestamp":1793061136708,"version":"4.5.0"},"reference-count":32,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Italian Ministry of Health"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Cancer represents a major concern in rheumatology. Epidemiological studies have demonstrated associations between rheumatic conditions and increased cancer risk at specific sites. However, comprehensive Italian epidemiological data on this association remain lacking. Methods: We conducted a nationwide retrospective cohort study using Italian Hospital Discharge Records from patients hospitalized between 1 January and 31 December 2018, with follow-up until 31 December 2023. Adult patients with Immune-mediated inflammatory diseases (IMID), including rheumatoid arthritis (RA) and diffuse diseases of connective tissue (DDCT), were the exposed group. The unexposed group included patients with primary diagnoses of injury and poisoning, with no IMID history. We used multivariable logistic regression models to assess cancer association, adjusting for demographics, geography, time of follow-up and comorbidities. Results: We included 54,896 IMID patients (exposed) and 301,126 unexposed. During the five-year follow-up, the IMID group was significantly associated with cancer (adjusted OR 1.32, 95% CI 1.27\u20131.38; p &lt; 0.001). The ORadj decreased over time, from 1.83 (p &lt; 0.001) in year one to 1.20 (p &lt; 0.001) from the fifth year onward. Significant association with lung cancer (ORadj 1.74; p &lt; 0.001), leukemia and lymphoma (ORadj 1.98; p &lt; 0.001), bladder (ORadj 1.48; p &lt; 0.001) and melanoma (ORadj 1.48; p = 0.009) were observed in the IMID group. DDCT patients showed an overall higher cancer risk (ORadj 1.53, p &lt; 0.001) than RA patients (ORadj 1.20, p &lt; 0.001). Conclusions: This first nationwide Italian study confirms an association with cancer in IMID patients, with the highest association in the first year post-diagnosis. The temporal decrease in cancer risk generates the hypothesis that inflammation, rather than medication, may be the primary driver. These findings support enhanced cancer surveillance in IMID patients, particularly during the first year after diagnosis.<\/jats:p>","DOI":"10.3390\/cancers18061027","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T08:47:42Z","timestamp":1774255662000},"page":"1027","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cancer Association in Patients with Immune-Mediated Inflammatory Diseases: A Five-Year Nationwide Italian Cohort Study"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4980-0132","authenticated-orcid":false,"given":"Barbara","family":"Giordani","sequence":"first","affiliation":[{"name":"Italian National Agency for Regional Healthcare Services (AGENAS), 00187 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"software","vocabulary":"credit"}]},{"given":"Luigi","family":"Pirtoli","sequence":"additional","affiliation":[{"name":"Sbarro Institute, College of Science and Technology\u2019s Biotechnology, Temple University, Philadelphia, PA 19122, USA"},{"name":"Department of Medical Biotechnology, University of Siena, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"resources","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2450-6025","authenticated-orcid":false,"given":"Guido","family":"Putignano","sequence":"additional","affiliation":[{"name":"bioERGOtech, 74123 Taranto, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"software","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5959-016X","authenticated-orcid":false,"given":"Antonio","family":"Giordano","sequence":"additional","affiliation":[{"name":"Sbarro Institute, College of Science and Technology\u2019s Biotechnology, Temple University, Philadelphia, PA 19122, USA"},{"name":"Department of Medical Biotechnology, University of Siena, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"validation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3255-3307","authenticated-orcid":false,"given":"Daniela","family":"Marotto","sequence":"additional","affiliation":[{"name":"Azienda Socio-Sanitaria Locale della Gallura, 07026 Olbia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"validation","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"conceptualization","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8313-794X","authenticated-orcid":false,"given":"Giovanni","family":"Baglio","sequence":"additional","affiliation":[{"name":"Italian National Agency for Regional Healthcare Services (AGENAS), 00187 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"validation","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cell.2014.03.004","article-title":"Coming full circle-from endless complexity to simplicity and back again","volume":"157","author":"Weinberg","year":"2014","journal-title":"Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of Cancer: New Dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e002896","DOI":"10.1136\/jitc-2021-002896","article-title":"Immune-related adverse events associated with immune checkpoint inhibitors: A call to action for collecting and sharing clinical trial and real-world data","volume":"9","author":"Reynolds","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.7150\/ijbs.92525","article-title":"Advancements in technology for characterizing the tumor immune microenvironment","volume":"20","author":"Yan","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"102658","DOI":"10.1016\/j.autrev.2020.102658","article-title":"Eight pillars of oncorheumatology: Crossroads between malignancies and musculoskeletal diseases","volume":"19","author":"Szekanecz","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"101472","DOI":"10.1016\/j.berh.2019.101472","article-title":"The relationships between cancer and autoimmune rheumatic diseases","volume":"34","author":"Cappelli","year":"2020","journal-title":"Best. Pract. Res. Clin. Rheumatol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Geng, Z., Ye, C., and Zhu, X. (2023). Malignancies in systemic rheumatic diseases: A mini review. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1095526"},{"key":"ref_9","unstructured":"Centers for Disease Control and Prevention (CDC) (2026, March 11). International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM), Available online: https:\/\/archive.cdc.gov\/#\/results?q=icd9cm&start=0&rows=10."},{"key":"ref_10","unstructured":"Medline (2025, June 21). Connective Tissue Disorders [Internet], Available online: https:\/\/medlineplus.gov\/connectivetissuedisorders.html."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2105\/AJPH.2012.300897","article-title":"Multivariate or multivariable regression?","volume":"103","author":"Hidalgo","year":"2013","journal-title":"Am. J. Public Health"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0021-9681(78)90071-1","article-title":"Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis","volume":"31","author":"Hakulinen","year":"1978","journal-title":"J. Chronic Dis."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Maier, J.A., Castiglioni, S., Petrelli, A., Cannatelli, R., Ferretti, F., Pellegrino, G., Sarzi Puttini, P., Fiorina, P., and Ardizzone, S. (2024). Immune-Mediated Inflammatory Diseases and Cancer\u2014A dangerous liaison. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1436581"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1186\/ar2404","article-title":"A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis","volume":"10","author":"Smitten","year":"2008","journal-title":"Arthritis Res. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13075-015-0728-9","article-title":"Incidence of malignancy in adult patients with rheumatoid arthritis: A meta-analysis","volume":"17","author":"Simon","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.berh.2019.03.011","article-title":"Malignancy and rheumatoid arthritis: Epidemiology, risk factors and management","volume":"32","author":"Hyrich","year":"2018","journal-title":"Best. Pract. Res. Clin. Rheumatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.semarthrit.2021.03.015","article-title":"Rheumatoid arthritis and risk of lung cancer: Meta-analysis and Mendelian randomization study","volume":"51","author":"Wu","year":"2021","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.rdc.2020.05.005","article-title":"Cancer and Systemic Lupus Erythematosus","volume":"46","author":"Ladouceur","year":"2020","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s13075-018-1760-3","article-title":"The risks of cancer development in systemic lupus erythematosus (SLE) patients: A systematic review and meta-analysis","volume":"20","author":"Song","year":"2018","journal-title":"Arthritis Res. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.rdc.2020.04.001","article-title":"Risk of Malignancy in Spondyloarthritis: A Systematic Review","volume":"46","author":"Karmacharya","year":"2020","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jamadermatol.2020.0024","article-title":"Prevalence, Incidence, and Risk of Cancer in Patients With Psoriasis and Psoriatic Arthritis: A Systematic Review and Meta-analysis","volume":"156","author":"Vaengebjerg","year":"2020","journal-title":"JAMA Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/art.23185","article-title":"Prevalence of malignancy in psoriatic arthritis","volume":"58","author":"Rohekar","year":"2008","journal-title":"Arthritis Rheum."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/art.38385","article-title":"A comparison of the malignancy incidence among patients with psoriatic arthritis and patients with rheumatoid arthritis in a large US cohort","volume":"66","author":"Gross","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/rheumatology\/key241","article-title":"Malignancy and mortality rates in patients with severe psoriatic arthritis requiring tumour-necrosis factor alpha inhibition: Results from the British Society for Rheumatology Biologics Register","volume":"58","author":"Fagerli","year":"2019","journal-title":"Rheumatology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.rdc.2020.05.004","article-title":"Sj\u00f6gren Syndrome and Cancer","volume":"46","author":"Igoe","year":"2020","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"103084","DOI":"10.1016\/j.autrev.2022.103084","article-title":"Primary Sj\u00f6gren\u2019s syndrome is associated with increased risk of malignancies besides lymphoma: A systematic review and meta-analysis","volume":"21","author":"Zhong","year":"2022","journal-title":"Autoimmun. Rev."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/BOR.0000000000000222","article-title":"Cancer and scleroderma: A paraneoplastic disease with implications for malignancy screening","volume":"27","author":"Shah","year":"2015","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.rdc.2020.03.002","article-title":"Cancer and Scleroderma","volume":"46","author":"Weeding","year":"2020","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"105557","DOI":"10.1016\/j.jbspin.2023.105557","article-title":"Cancer screening in chronic inflammatory rheumatic diseases","volume":"90","author":"Kedra","year":"2023","journal-title":"Jt. Bone Spine"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"100768","DOI":"10.1016\/j.lanepe.2023.100768","article-title":"Risk of cancer for patients with rheumatoid arthritis versus general population: A national claims database cohort study","volume":"35","author":"Beydon","year":"2023","journal-title":"Lancet Reg. Health Eur."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Veettil, S.K., Lim, K.G., Ching, S.M., Saokaew, S., Phisalprapa, P., and Chaiyakunapruk, N. (2017). Effects of aspirin and non-aspirin nonsteroidal anti-inflammatory drugs on the incidence of recurrent colorectal adenomas: A systematic review with meta-analysis and trial sequential analysis of randomized clinical trials. BMC Cancer, 17.","DOI":"10.1186\/s12885-017-3757-8"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"5758","DOI":"10.36922\/cp.5758","article-title":"Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in hepatocellular carcinoma: From inflammation to clinical applications","volume":"6","author":"Zarlashat","year":"2024","journal-title":"Cancer Plus"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/6\/1027\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T04:14:53Z","timestamp":1792988093000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/6\/1027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":32,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["cancers18061027"],"URL":"https:\/\/doi.org\/10.3390\/cancers18061027","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]}}}